CVI Holdings’s Kezar Life Sciences KZR Stock Holding History

CVI Holdings’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,375	Closed	-$486K	–	103
2020 Q2	$486K	Buy	+9,375	New	+$473K	0.18%	47

Other funds holding KZR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CVI Holdings's KZR Position: Q3 2020 in Review

CVI Holdings sold out of Kezar Life Sciences (KZR) in Q3 2020, closing a stake of 9,375 shares — an estimated $486K sold.

CVI Holdings first reported a position in KZR in Q2 2020 and held it in 1 quarter. The position peaked at $486K in Q2 2020. 78 funds tracked by Wall St. Rank hold KZR as of Q3 2020.

CVI Holdings reported no remaining Kezar Life Sciences position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 9,375 Kezar Life Sciences shares in Q3 2020, an estimated $486K.
CVI Holdings first reported a position in Kezar Life Sciences in Q2 2020 and held it in 1 quarter.
CVI Holdings's Kezar Life Sciences position peaked at $486K in Q2 2020.
78 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.